Biodesix to present at the canaccord genuity 42nd annual growth conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer of biodesix, will present at the canaccord genuity 42nd annual growth conference being held august 8-11, 2022. canaccord genuity 42nd annual growth conference date: wednesday, august 10, 2022 time: 3:00 pm et location: intercontinental boston the presentation will be webcast live and available for r
BDSX Ratings Summary
BDSX Quant Ranking